The value of the cross-section of 226Pa production by the 232Th(p, 7n) reaction for 155 MeV protons, obtained by comparison with 227Pa, is 1 ± 0.3 mb.La valeur de la section-efficace de formation de 226Pa par la réaction 232Th(p, 7n), déterminée par rapport à celle de 227Pa, est, à 155 MeV, de 1 ± 0.3 mb
The production cross-sections of proton-rich protactinium and thorium isotopes have been investigate...
Cross-section measurements were made on the formation of several isotopes of thorium, and actinium, ...
International audienceIntroduction: 226Th (T1/2 = 31 min) is a promising therapeutic radionuclide si...
225Ac [Actinium-225] is a promising radionuclide for targeted alpha therapy of cancer. 229Pa can lea...
Actinium-225 has important medical applications as an agent for targeted alpha therapy, but existing...
A procedure is described for the accelerator production of 232 Pa and its isolation in radiochemical...
Excitation functions of isotopes 227, 228 and 230 of protactinium were obtained by bombarding thoriu...
Cross sections have been measured for the production of actinium isotopes (224 to 228) in the bombar...
International audienceThe irradiation of a thorium target by light charged particles (protons and de...
The experimental cross sections of Pa-230 formation in the reaction 232Th(p,3n)230Pa for the protons...
A procedure is described for the accelerator production of 232pa and its isolation in radio-chemical...
230U and its daughter nuclide 226Th are novel therapeutic nuclides for application in targeted r-the...
From measurements of cross sections of several isotopes of polonium (206 to 210) and astatine (206 t...
To study fission characteristics of protactinium-232, the isotope under investigation was built up i...
230U/226Th is a promising novel alpha-emitter system for application in targeted alpha therapy of ca...
The production cross-sections of proton-rich protactinium and thorium isotopes have been investigate...
Cross-section measurements were made on the formation of several isotopes of thorium, and actinium, ...
International audienceIntroduction: 226Th (T1/2 = 31 min) is a promising therapeutic radionuclide si...
225Ac [Actinium-225] is a promising radionuclide for targeted alpha therapy of cancer. 229Pa can lea...
Actinium-225 has important medical applications as an agent for targeted alpha therapy, but existing...
A procedure is described for the accelerator production of 232 Pa and its isolation in radiochemical...
Excitation functions of isotopes 227, 228 and 230 of protactinium were obtained by bombarding thoriu...
Cross sections have been measured for the production of actinium isotopes (224 to 228) in the bombar...
International audienceThe irradiation of a thorium target by light charged particles (protons and de...
The experimental cross sections of Pa-230 formation in the reaction 232Th(p,3n)230Pa for the protons...
A procedure is described for the accelerator production of 232pa and its isolation in radio-chemical...
230U and its daughter nuclide 226Th are novel therapeutic nuclides for application in targeted r-the...
From measurements of cross sections of several isotopes of polonium (206 to 210) and astatine (206 t...
To study fission characteristics of protactinium-232, the isotope under investigation was built up i...
230U/226Th is a promising novel alpha-emitter system for application in targeted alpha therapy of ca...
The production cross-sections of proton-rich protactinium and thorium isotopes have been investigate...
Cross-section measurements were made on the formation of several isotopes of thorium, and actinium, ...
International audienceIntroduction: 226Th (T1/2 = 31 min) is a promising therapeutic radionuclide si...